Cargando…
Dracorhodin targeting CMPK2 attenuates inflammation: A novel approach to sepsis therapy
BACKGROUND: Despite all modern advances in medicine, an effective drug for treating sepsis has yet to be found. The discovery of CMPK2 spurred hopes for the treatment of sepsis. However, CMPK2‐untapped target inhibitors are still an enormous obstacle that has hindered the CMPK2‐centric treatment of...
Autores principales: | Zhang, Wendan, Jiang, Honghong, Huang, Pengli, Wu, Gaosong, Wang, Qun, Luan, Xin, Zhang, Hongwei, Yu, Dianping, Wang, Hongru, Lu, Dong, Wang, Haonan, An, Huazhang, Liu, Sanhong, Zhang, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587737/ https://www.ncbi.nlm.nih.gov/pubmed/37859535 http://dx.doi.org/10.1002/ctm2.1449 |
Ejemplares similares
-
The pathogenesis and potential therapeutic targets in sepsis
por: Zhang, Wendan, et al.
Publicado: (2023) -
Pharmacodynamics of Dracorhodin Perchlorate and Its Inflammation-Targeting Emulsion Gel for Wound Healing
por: Wang, Xiaojie, et al.
Publicado: (2022) -
Molecular mechanisms of ferroptosis and its antitumor applications in natural products: Ferroptosis and applications in natural products
por: Yu, Dianping, et al.
Publicado: (2023) -
Dracorhodin Perchlorate Accelerates Cutaneous Wound Healing in Wistar Rats
por: Jiang, Xiao-wen, et al.
Publicado: (2017) -
Dracorhodin perchlorate induces the apoptosis of glioma cells
por: Chen, Xin, et al.
Publicado: (2021)